Skip to main content
SpringerLink
Log in

Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: Identification of metabolites by gas chromatography/ mass spectrometry

  • Published:
European Journal of Drug Metabolism and Pharmacokinetics Aims and scope Submit manuscript

Summary

Metabolic pathways of simvastatin (MK-733), a lactone prodrug of an inhibitor of HMG-CoA reductase, were elucidated in male rats, using the [14C]-labelled compound. Evidence has been obtained for hydrolysis of simvastatin and its metabolites at their 2,2-dimethylbutyryl moieties. Metabolites identified in plasma were 2,2-dimethylbutyric acid (DMB), 2,2-dimemyl-3-hydroxybutyric acid (DMHB) and an open chain hydroxy acid of simvastatin: metabolites identified in urine were DMHB, a glucuronide and the glycine conjugate of DMB. They were characterized by gas chromatography/electron impact and chemical ionization mass spectrometry as phenacyl or pertrimethylsilylated derivatives. The structures of the metabolites and the aglycone of the glucuronide were confirmed as phenacyl esters by comparison of their chromatographic data and mass spectra with those of the phenacyl derivatives of authentic compounds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Illingworth D.R., Bacon S. (1987): Hypolipidemic effects of HMG-CoA reductase inhibitors in patients with hypercholesterolemia. Am. J. Cardiol., 60, 33G-42G.

    Article  CAS  PubMed  Google Scholar 

  2. Endo A. (1988): Chemistry, biochemistry and pharmacology of HMG-CoA reductase inhibitors. Klin. Wochenschr., 66, 421–427.

    Article  CAS  PubMed  Google Scholar 

  3. Alberts A.W., Chen J., Kuron G., et al. (1980): Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent Ptoc. Natl. Acad. Sci. USA, 77, 3957–3961.

    Article  CAS  Google Scholar 

  4. Tsujita Y., Kuroda M., Shimada Y., et al. (1986): CS-514, a competitive inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase: tissue-selective inhibition of sterol synthesis and hypolipidemic effect on various animal species. Biochim. Biophys. Acta, 877, 50–60.

    CAS  PubMed  Google Scholar 

  5. Hoffman W.F., Alberts A.W., Anderson P.S., Chen J.S., Smith R.L., Willard A.K. (1986): 3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin. J. Med. Chem., 29, 849–852.

    Article  CAS  PubMed  Google Scholar 

  6. Alberts A.W., Chen J., Huff J., Hunt V., Kuron G. (1986): Comparative studies on the hydroxymethyl-glutaryl coenzyme A reductase inhibitors mevinolin, MK-733 and CS-514. Proc. IXth Int Symp. Drugs Affect Lipid Metab., (Florence), 8.

  7. Ishida F., Sato A., Iizuka Y., Sawasaki Y., Aizawa A., Kamei T. (1988): Effects of MK-733, an inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase, on absorption and excretion of [3H]-cholcsterol in rabbits. Biochim. Biophys. Acta, 963, 35–41.

    CAS  PubMed  Google Scholar 

  8. Kobayashi M., Ishida F., Takahashi T., et al. (1989): Preventive effect of MK-733 (simvastatin), an inhibitor of HMG-CoA reductase, on hypercholesterolemia and atherosclerosis induced by cholesterol feeding in rabbits. Jap. J. Pharmacol., 49, 125–133.

    Article  CAS  PubMed  Google Scholar 

  9. Mol M.J.T.M., Erkelens D.W., Leuven J.A.G., Schouten J.A., Stalenhoef A.F.H. (1986): Effects of synvinolin (MK-733) on plasma lipids in familial hypercholesterolaemia. Lancet, ii, 936–939.

    Article  Google Scholar 

  10. Simons L.A., Nestel P.J., Calvert G.D., Jennings G.L. (1987): Effects of MK-733 on plasma lipid and lipoprotein levels in subjects with hypercholesterolaemia. Med. J. Aust., 147, 65–68.

    CAS  PubMed  Google Scholar 

  11. Walker J.F., Tobert J.A. (1987): The clinical efficacy and safety of lovastatin and MK-733 — an overview. Eur. Heart J., 8, 93–96.

    PubMed  Google Scholar 

  12. Mol M.J.T.M., Erkelens D.W., Leuven J.A.G., Schouten J.A., Stalenhoef A.F.H. (1988): Simvastatin (MK-733): a potent cholesterol synthesis inhibitor in heterozygous familial hypercholesterolaemia. Atherosclerosis, 69, 131–137.

    Article  CAS  PubMed  Google Scholar 

  13. Mol M.J.T.M., Stuyt P.M.J., Stalenhoef A.F.H. (1989): Effectiviteit veiligheid van simvastatine, een nieuw cholesterolverlagend geneesmiddel. Ned. Tijdschr. Geneeskd., 133, 362–366.

    CAS  PubMed  Google Scholar 

  14. Leclercq V, Harvengt C. (1989): Simvastatin (MK-733) in heterozygous familial hypercholesterolemia: a two-year trial. Int. J. Clin. Pharmacol. Ther. Toxicol., 27, 76–81.

    CAS  PubMed  Google Scholar 

  15. Pietro D.A., Alexander S., Mantell G., Staggers J.E., Cook T.J. (1989): Effects of simvastatin and probucol in hypercholesterolemia (simvastatin multicenter study group II). Am. J. Cardiol., 63, 682–686.

    Article  CAS  PubMed  Google Scholar 

  16. Grundy S.M. (1988): HMG-CoA reductase inhibitors for treatment of hypercholesterolemia. N. Engl. J. Med., 319, 24–33.

    Article  CAS  PubMed  Google Scholar 

  17. Germershausen J.I., Hunt V.M., Bostedor R.G., Bailey P.J., Karkas J.D., Alberts A.W. (1989): Tissue selectivity of the cholesterol-lowering agents lovastatin, simvastatin and pravastatin in rats in vivo. Biochem. Biophys. Res. Commun., 158, 667–675.

    Article  CAS  PubMed  Google Scholar 

  18. Greenspan M.D., Yudkovitz J.B., Alberts A.W., Argenbright L.S., Arison B.H., Smith J.L. (1988): Metabolism of lovastatin by rat and human liver microsomes in vitro. Drug Metab. Dispos., 16, 678–682.

    CAS  PubMed  Google Scholar 

  19. Duggan D.E. (1988): The physiological disposition of lovastatin. Proc. 8th Int. Symp. Atherosclerosis (Rome), 1067.

  20. Vyas K.P. (1988): Metabolism of lovastatin and simvastatin by rat and mouse liver microsomes. Proc. 8th Int. Symp. Atherosclerosis (Rome), 1068.

  21. Duggan D.E., Chen I-W., Bayne W.F., et al. (1989): The physiological disposition of lovastatin. Drug Metab. Dispos., 17, 166–173.

    CAS  PubMed  Google Scholar 

  22. Ohtawa M., Uchiyama N., Saito Y., et al. (1989): Phase I study of MK-733, an inhibitor of HMG-CoA reductase II: pharmacokinetics of MK-733 in healthy subjects after single and multiple oral administration. J. Clin. Ther. Med., 5, 1123–1140.

    Google Scholar 

  23. Clark J.H., Miller J.M. (1977): Hydrogen bonding in organic synthesis V: Potassium fluoride in carboxylic acids as an alternative to crown ether with acid salts in the preparation of phenacyl esters. Tetrahedron Lett., 7, 599–602.

    Article  Google Scholar 

  24. Hendrickson J.B., Kandall C. (1970): The phenacyl protecting group for acids and phenols. Tetrahedron Lett., 5, 343–344.

    Article  Google Scholar 

  25. Kuhara T., Matsumoto I., Ohno M., Ohura T. (1986): Identification and quantification of octanoyl glucuronide in the urine of children who ingested medium-chain triglycerides. Biomed. Environ. Mass Spectrom., 13, 595–598.

    Article  CAS  PubMed  Google Scholar 

  26. Breeman R.B., Stogniew M., Fenselau C. (1988): Characterization of acyl-linked glucuronides by electron impact and fast atom bombardment mass spectrometry. Biomed. Environ. Mass Spectrom., 17, 97–103.

    Article  Google Scholar 

  27. Kuhara T., Hirokata Y., Yamada S., Matsumoto I. (1978): Metabolism of sodium dipropylacetate in human. Eur. J. Drug. Metab., 9, 171–177.

    Article  Google Scholar 

  28. Vickers S., Duncan C.A.H., White S.D., et al. (1985): Carnitine and glucuronic acid conjugates of pivalic acid. Xenobiotica, 15, 453–458.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Central Research Laboratories, Banyu Pharmaceutical Co. Ltd, No. 9-3, 2-Chome, Shimomeguro, Meguro-ku, 153, Tokyo, Japan

    N. Uchiyama, Y. Kagami, Y. Saito, S. Abe, M. Ohtawa & S. Hata

Authors
  1. N. Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Y. Kagami
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Y. Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Abe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Ohtawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Hata
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uchiyama, N., Kagami, Y., Saito, Y. et al. Metabolic fate of 2,2-dimethylbutyryl moiety of simvastatin in rats: Identification of metabolites by gas chromatography/ mass spectrometry. European Journal of Drug Metabolism and Pharmacokinetics 16, 189–196 (1991). https://doi.org/10.1007/BF03189958

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03189958

Keywords

Search

Navigation